Persones / Equip Humà

Francesc Villarroya Gombau

Buscador de publicacions

Publicacions

  • Planavila A, Redondo-Angulo I and Villarroya-Gombau F.

    FGF21 and Cardiac Physiopathology.

    Frontiers in Endocrinology . 6: 133-133. Nº de cites: 87

    [doi:10.3389/fendo.2015.00133]

  • Cereijo R, Gallego-Escuredo JM, Moure R, Villarroya-Terrade J, Domingo JC, Fontdevila J, Martínez E, Gutiérrez Mdel M, Mateo MG, Giralt M, Domingo P and Villarroya-Gombau F.

    The Molecular Signature of HIV-1-Associated Lipomatosis Reveals Differential Involvement of Brown and Beige/Brite Adipocyte Cell Lineages.

    PLoS One . 10(8): . Nº de cites: 18

    [doi:10.1371/journal.pone.0136571]

  • Cereijo R, Villarroya-Terrade J and Villarroya-Gombau F.

    Non-sympathetic control of brown adipose tissue.

    International journal of obesity supplements . 5(Suppl 1): .

    [doi:10.1038/ijosup.2015.10]

  • Chung SY, Kao CH, Villarroya-Gombau F, Chang HY, Chang HC, Hsiao SP, Liou GG and Chen SL.

    Bhlhe40 Represses PGC-1a Activity on Metabolic Gene Promoters in Myogenic Cells.

    MOLECULAR AND CELLULAR BIOLOGY . 35(14): 2518-2529. Nº de cites: 17

    [doi:10.1128/MCB.00387-15]

  • Malandrino MI, Fucho R, Weber M, Calderon-Dominguez M, Mir JF, Valcarcel L, Escoté X, Gómez-Serrano M, Peral B, Salvadó L, Fernández-Veledo S, Casals N, Vazquez M, Villarroya-Gombau F, Vendrell JJ, Serra D and Herrero L.

    Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation.

    AM J PHYSIOL-ENDOC M . 308(9): . Nº de cites: 153

    [doi:10.1152/ajpendo.00362.2014]

  • Sánchez-Infantes D, Gallego-Escuredo J, Díaz-Silva M, Aragonès G, Sebastiani G, López-Bermejo A, de Zegher F, Domingo P, Villarroya-Gombau F and Ibañez-Toda L.

    Circulating FGF19 and FGF21 surge in early infancy from infra- to supra-adult concentrations

    INTERNATIONAL JOURNAL OF OBESITY . 39(5): 742-746. Nº de cites: 27

    [doi:10.1038/ijo.2015.2]

  • Planavila A, Redondo-Angulo I, Ribas F, Garrabou G, Casademont J, Giralt M and Villarroya-Gombau F.

    Fibroblast growth factor 21 protects the heart from oxidative stress.

    CARDIOVASCULAR RESEARCH . 106(1): 19-31. Nº de cites: 218

    [doi:10.1093/cvr/cvu263]

  • Cereijo R, Giralt M and Villarroya-Gombau F.

    Thermogenic brown and beige/brite adipogenesis in humans.

    ANNALS OF MEDICINE . 47(2): 169-177. Nº de cites: 69

    [doi:10.3109/07853890.2014.952328]

  • Sheedfar F, Vermeer M, Pazienza V, Villarroya-Terrade J, Rappa F, Cappello F, Mazzoccoli G, Villarroya-Gombau F, van der Molen H, Hofker MH, Koonen DP and Vinciguerra M.

    Genetic ablation of macrohistone H2A1 leads to increased leanness, glucose tolerance and energy expenditure in mice fed a high-fat diet.

    INTERNATIONAL JOURNAL OF OBESITY . 39(2): 331-338. Nº de cites: 20

    [doi:10.1038/ijo.2014.91]

  • Domingo P, Lamarca MK, Gallego-Escuredo JM, Torres F, Domingo JC, Villarroya-Terrade J, Gutierrez Mdel M, Mateo MG, Vidal F, Villarroya-Gombau F and Giralt M.

    Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients.

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 70(6): 1825-1832. Nº de cites: 11

    [doi:10.1093/jac/dkv027]